Hematopoietic stem cell transplantation in nonmalignant diseases.

  title={Hematopoietic stem cell transplantation in nonmalignant diseases.},
  author={Rainer F Storb},
  journal={The Journal of rheumatology. Supplement},
  • Rainer F Storb
  • Published 1997 in The Journal of rheumatology. Supplement
Treatment of patients with nonmalignant hematopoietic diseases by marrow grafts from HLA identical family members has progressed to a point where event free survivals of 75-90% can be expected. For allografts to be successful, conditioning programs have been devised that provide both the immunosuppression and the marrow space required for the incoming grafts to be accepted. Despite graft versus host disease prevention with methotrexate and cyclosporine, the acute and chronic forms of this… CONTINUE READING


Publications citing this paper.
Showing 1-4 of 4 extracted citations

Combination Treatment in Autoimmune Diseases

N. Fathyl, Daniel e. Furst
Springer Berlin Heidelberg • 2002
View 5 Excerpts
Highly Influenced

High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation • 2002
View 1 Excerpt

Similar Papers

Loading similar papers…